Development of a CHO cell line for stable production of recombinant antibodies against human MMP9

BACKGROUND: Human matrix metalloproteinase 9 (hMMP9) is a biomarker in several diseases, including cancer, and the need for developing detectors and inhibitors of hMMP9 is increasing. As an antibody against hMMP9 can be selectively bound to hMMP9, the use of anti-MMP9 antibody presents new possibili...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Jina, Kim, Eun-Jung, Kim, Joo-Kyung, Park, Tai Hyun, Kim, Byung-Gee, Jeong, Hee-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903741/
https://www.ncbi.nlm.nih.gov/pubmed/35255869
http://dx.doi.org/10.1186/s12896-022-00738-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903741/
https://www.ncbi.nlm.nih.gov/pubmed/35255869
http://dx.doi.org/10.1186/s12896-022-00738-6

Ejemplares similares